

Colgate-Palmolive vs Coca-Cola Europacific Partners
Global oral care and household products leader vs Major Coca-Cola bottler across Europe and Asia-Pacific. Which is the better buy for your portfolio in September 2026? Plain-English answer below.
Colgate-Palmolive vs Coca-Cola Europacific Partners sets a household staples giant against a major bottling and distribution powerhouse, two companies that depend on massive operational scale and deep brand loyalty to move everyday products off shelves across dozens of global markets. Both businesses have built pricing power into their DNA, leaning on brand equity to push through cost inflation without meaningfully losing shoppers. This comparison explores how Colgate-Palmolive vs Coca-Cola Europacific Partners each navigates volume versus price trade-offs, geographic mix shifts, and the relentless investor demand for steady earnings and dividend growth.
Colgate-Palmolive vs Coca-Cola Europacific Partners sets a household staples giant against a major bottling and distribution powerhouse, two companies that depend on massive operational scale and deep...
Why It’s Moving

Colgate-Palmolive Maintains Dividend Streak While Expanding Natural Oral Care Portfolio
- The Board of Directors declared a quarterly cash dividend of $0.53 per common share, payable on November 13, 2026, to shareholders of record on October 20, 2026.
- Tom's of Maine launched Hydroxyapatite Toothpaste, a fluoride-free product formulated with naturally derived Calcium Carbonate and Arginine to meet rising demand for natural oral care solutions.
- Analysts continue to highlight Colgate-Palmolive’s strong market position in consumer staples, comparing its portfolio breadth and digital investment strategies against peers like Procter & Gamble.

CCEP faces a fresh analyst downgrade as buybacks temper, but do not erase, downside concerns.
- A research firm lowered CCEP from Buy to Hold on September 18, signaling that its near-term risk-reward profile has become less compelling after the recent share-price advance.
- CCEP repurchased 403,748 shares between September 7 and 11 under its ongoing buyback program, supporting per-share value but offering only a partial counterweight to valuation concerns.
- The resignation of independent director Nathalie Gaveau, effective September 16, adds a governance development for investors to monitor, although the company did not indicate an operational disruption.

Colgate-Palmolive Maintains Dividend Streak While Expanding Natural Oral Care Portfolio
- The Board of Directors declared a quarterly cash dividend of $0.53 per common share, payable on November 13, 2026, to shareholders of record on October 20, 2026.
- Tom's of Maine launched Hydroxyapatite Toothpaste, a fluoride-free product formulated with naturally derived Calcium Carbonate and Arginine to meet rising demand for natural oral care solutions.
- Analysts continue to highlight Colgate-Palmolive’s strong market position in consumer staples, comparing its portfolio breadth and digital investment strategies against peers like Procter & Gamble.

CCEP faces a fresh analyst downgrade as buybacks temper, but do not erase, downside concerns.
- A research firm lowered CCEP from Buy to Hold on September 18, signaling that its near-term risk-reward profile has become less compelling after the recent share-price advance.
- CCEP repurchased 403,748 shares between September 7 and 11 under its ongoing buyback program, supporting per-share value but offering only a partial counterweight to valuation concerns.
- The resignation of independent director Nathalie Gaveau, effective September 16, adds a governance development for investors to monitor, although the company did not indicate an operational disruption.
Investment Analysis
Pros
- Colgate-Palmolive achieved organic sales growth of 2.4% in Q2 2025, demonstrating resilience despite inflation and foreign exchange headwinds.
- The company maintains a strong global market position in household and personal care products, supported by high gross profit margins of over 60%.
- Colgate-Palmolive offers a stable dividend yield of around 2.7%, appealing to income-focused investors seeking consistent returns.
Considerations
- The stock trades at a premium valuation, with a P/E ratio above sector average, which may limit upside for new investors.
- Recent analyst price targets have been lowered, reflecting concerns about future growth and limited share price appreciation over the past year.
- Colgate-Palmolive faces ongoing exposure to raw material cost pressures and currency volatility, which could impact profitability.
Pros
- Coca-Cola Europacific Partners benefits from strong brand recognition and a dominant position in the European and Pacific beverage markets.
- The company has demonstrated consistent revenue growth, supported by a diversified product portfolio and strategic distribution networks.
- It maintains healthy operating margins and a solid return on equity, reflecting efficient capital allocation and operational discipline.
Considerations
- The business is exposed to regulatory risks and changing consumer preferences, particularly around sugar content and health concerns.
- Coca-Cola Europacific Partners faces competitive pressures from both global and local beverage brands, which could constrain pricing power.
- The company's performance is sensitive to macroeconomic factors, including inflation and currency fluctuations, especially in its international markets.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (NYSE: CL) is scheduled to report its next earnings on October 30, 2026. The release will cover fiscal third-quarter 2026 results for the quarter ended September 30, 2026. Current estimates point to a pre-market report, subject to confirmation by the company.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next scheduled earnings-related update is November 3, 2026. It is expected to cover the company’s third quarter of fiscal 2026. The release is likely to be a Q3 trading update rather than a full quarterly earnings report, consistent with CCEP’s reporting pattern.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (NYSE: CL) is scheduled to report its next earnings on October 30, 2026. The release will cover fiscal third-quarter 2026 results for the quarter ended September 30, 2026. Current estimates point to a pre-market report, subject to confirmation by the company.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next scheduled earnings-related update is November 3, 2026. It is expected to cover the company’s third quarter of fiscal 2026. The release is likely to be a Q3 trading update rather than a full quarterly earnings report, consistent with CCEP’s reporting pattern.
Buy CL or CCEP in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


